𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-CD38 autoantibodies in type? diabetes

✍ Scribed by Roberto Mallone; Paolo Cavallo Perin

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
399 KB
Volume
22
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anti-ganglioside autoantibodies in type
Anti-ganglioside autoantibodies in type 1 diabetes
✍ Marta Lucchetta; Salvatore Rudilosso; Silvana Costa; Daniela Bruttomesso; Susann πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 66 KB

## Abstract Type 1 diabetes is an autoimmune disease that is accompanied by an immune response against pancreatic cells. As gangliosides are expressed in both peripheral nerves and pancreatic cells, we examined the possibility of correlation between type 1 diabetes, anti‐ganglioside autoantibodies,

Anti-CD3 mAbs for treatment of type 1 di
Anti-CD3 mAbs for treatment of type 1 diabetes
✍ Adam Kaufman; Kevan C. Herold πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract The use of anti‐CD3 monoclonal antibodies (mAbs) has moved from the bench to the bedside. The experience with the anti‐human CD3 mAb OKT3 for treatment of transplant rejection identified limitations that were largely overcome with the creation of humanized non‐FcR binding antibodies: Te

Anti-Glycosphingolipid autoantibodies in
Anti-Glycosphingolipid autoantibodies in rheumatologic disorders
✍ Dr. Roberto S. Zeballos; Robert I. Fox; David A. Cheresh; Richard A. McPherson πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 472 KB

Antibodies directed against ganglioside GMl or sulfatides are frequently associated with motor or sensorimotor neuropathies. To establish the prevalence of such antiglycosphingolipid autoantibodies in autoimmune disorders and to determine whether they contribute to neurologic symptoms in those indiv